BMO Capital Markets reissued their buy rating on shares of Physicians Realty Trust (NYSE:DOC) in a research report released on Monday morning. They currently have a $18.00 price objective on the real estate investment trust’s stock.
A number of other analysts have also recently commented on the company. Zacks Investment Research cut Physicians Realty Trust from a hold rating to a sell rating in a research report on Tuesday, January 30th. Morgan Stanley dropped their price target on Physicians Realty Trust from $18.00 to $16.50 and set an equal weight rating on the stock in a research report on Tuesday, March 20th. Robert W. Baird reissued an outperform rating and issued a $19.00 price target (down from $21.00) on shares of Physicians Realty Trust in a research report on Friday, January 5th. Bank of America dropped their price target on Physicians Realty Trust from $19.50 to $18.00 and set a buy rating on the stock in a research report on Thursday, March 8th. Finally, TheStreet cut Physicians Realty Trust from a b- rating to a c rating in a research report on Wednesday, February 28th. Six research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has an average rating of Buy and an average price target of $18.11.
Shares of DOC opened at $15.21 on Monday. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.58. Physicians Realty Trust has a 52 week low of $14.13 and a 52 week high of $21.85. The company has a market capitalization of $2,737.28, a PE ratio of 14.63, a P/E/G ratio of 3.13 and a beta of 0.46.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 18th. Investors of record on Tuesday, April 3rd were given a $0.23 dividend. The ex-dividend date was Monday, April 2nd. This represents a $0.92 annualized dividend and a yield of 6.05%. Physicians Realty Trust’s dividend payout ratio (DPR) is presently 88.46%.
In other Physicians Realty Trust news, Director Tommy G. Thompson acquired 13,650 shares of the stock in a transaction that occurred on Tuesday, March 6th. The shares were acquired at an average cost of $14.71 per share, with a total value of $200,791.50. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 0.53% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the stock. Nisa Investment Advisors LLC lifted its position in Physicians Realty Trust by 355.1% in the 4th quarter. Nisa Investment Advisors LLC now owns 6,280 shares of the real estate investment trust’s stock valued at $113,000 after acquiring an additional 4,900 shares in the last quarter. Cypress Wealth Services LLC bought a new position in Physicians Realty Trust in the 4th quarter valued at approximately $180,000. Greenwood Capital Associates LLC bought a new position in Physicians Realty Trust in the 4th quarter valued at approximately $194,000. Zeke Capital Advisors LLC bought a new position in Physicians Realty Trust in the 4th quarter valued at approximately $209,000. Finally, Xact Kapitalforvaltning AB bought a new position in Physicians Realty Trust in the 4th quarter valued at approximately $262,000. 94.10% of the stock is currently owned by institutional investors and hedge funds.
About Physicians Realty Trust
Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing high quality healthcare.
Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.